Specifically, we show that connectome gradients (i) are altered in AD, (ii) align with pathological (PET-derived) gradients and play a role in facilitating pathology progression, and (iii) interact with tau to affect cognition. The gene discussed is MAPT; the disease is Alzheimer disease.